AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

LABT · NASDAQ · Biotechnology

Lakewood-Amedex Biotherapeutics

Develops topical Nu-3 gel for mildly infected diabetic foot ulcers.

$2.96

Pre-market+0.45 (+17.93%)

At close$2.51(+9.13%)

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

	Insiders4 holders · as of May 1, 2026	5.11%	121.2K shares
	Otherremainder	94.89%	2.25M shares

2.37M company shares as of Sep 1, 2026 · holders as of their latest filing

Two share counts disagree (2.37M in the company's Sep 1, 2026 report, 1.75M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Peter CeccacciInsiderofficer: Chief Financial Officer	1.98%	46,815	Form 4filed May 1, 2026 ↗
Kelvin CooperInsiderdirector, officer: Chief Executive Officer	1.27%	30,059	Form 4filed May 1, 2026 ↗
Thomas BalzerInsiderofficer: Chief Medical Officer	1.08%	25,532	Form 4filed May 1, 2026 ↗
Leonard James DeRomaInsiderdirector	0.79%	18,774	Form 4filed May 1, 2026 ↗
HPW Investments Holding Ltd.Strategic	—24.04% of class, as filed	—	13Gfiled Jun 23, 2026 ↗
Joseph Edward TuckerInsiderdirector	0.00%	0	Form 4filed May 6, 2026 ↗
WFI Equity, LLCStrategic	—8.80% of class, as filed	—	13Gfiled Aug 14, 2026 ↗

13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F

No 13F holders on record.

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
HPW Investments Holding Ltd.	24.04%	3.44M	13G	Jun 23, 2026 ↗
WFI Equity, LLC	8.80%	1.26M	13G	Aug 14, 2026 ↗

Lakewood-Amedex Biotherapeutics

Breakdown13F · 13D/G · Form 4

Top shareholders13F · 13D/G · Form 4

Institutions13F

Ownership statements13D/G · 5% or more, as filed

Insider tradesForm 4

Latest trades

CongressHouse and Senate disclosures